Back to Search
Start Over
Phase II study of fixed‐duration single‐agent ibrutinib in relapsed nodular lymphocyte‐predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group
- Source :
- Hematological Oncology. 40:801-804
- Publication Year :
- 2022
- Publisher :
- Wiley, 2022.
- Subjects :
- Cancer Research
Oncology
Medizin
Hematology
General Medicine
Subjects
Details
- ISSN :
- 10991069 and 02780232
- Volume :
- 40
- Database :
- OpenAIRE
- Journal :
- Hematological Oncology
- Accession number :
- edsair.doi.dedup.....3032a95991537c47741a4b81a1fbe51a